Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
UZEDY: Information from Industry
View All
Sergio Traversa, PharmD
JCP
Original Research
Long-Term Safety and Efficacy of Esmethadone in MDD
February 17, 2025
A durable improvement in MDD symptoms for up to 1 year was observed with esmethadone with high rates of response and remission.
Maurizio Fava
,
Luca Pani
,
Sara De Martin
, et al
JCP
Original Research
Esmethadone in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
June 17, 2024
Although this trial of esmethadone did not meet its primary outcome, some secondary and post hoc outcomes were promising.
Maurizio Fava
,
Luca Pani
,
Sara De Martin
, et al
